Literature DB >> 11888259

Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels.

J Peltola1, J Laaksonen, A M Haapala, M Hurme, S Rainesalo, T Keränen.   

Abstract

Cerebrospinal fluid (CSF) and peripheral blood pleocytosis have been observed after epileptic seizures without any evidence of infections, but no systematic studies on the acute phase reaction in such patients have been performed. We have previously reported increased levels of interleukin-6 (IL-6) in patients with recent tonic--clonic seizures. Because IL-6 is a major inducer of the systemic acute phase reaction, we decided to study various indicators of inflammation in the blood as well as their correlation with plasma and CSF IL-6 levels. CSF and blood samples were studied from 37 patients with previously undiagnosed and untreated tonic-clonic seizures without any clinical evidence of systemic or central nervous system infections as well as from 40 controls. The mean peripheral blood and CSF-leukocyte counts were significantly higher in patients compared with controls ( 7.9 x 10(9)vs. 6.1 x 10(9), P= 0.002 and 1.9 x 10(6)vs. 1.1 x 10(6), P= 0.032, respectively). There was some indication of increased concentration of C-reactive protein (CRP) and no difference in haptoglobin levels. There was a significant correlation between plasma but not CSF IL-6 concentration and those of both B-leukocyte count ( r= 0.051, P= 0.009) and CRP ( r= 0.42, P= 0.009). Epileptic seizures provoke a production of cytokines such as IL-6 that may in turn cause an activation of the acute phase reaction. Thus, CSF pleocytosis and increase in some indicators of inflammation should not automatically be attributed to systemic or CNS infections in patients with acute seizures. Copyright 2002 BEA Trading Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888259     DOI: 10.1053/seiz.2001.0575

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  22 in total

Review 1.  Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy.

Authors:  Bruce Hermann; Michael Seidenberg; Mark Sager; Cynthia Carlsson; Barry Gidal; Raj Sheth; Paul Rutecki; Sanjay Asthana
Journal:  Epilepsia       Date:  2007-11-21       Impact factor: 5.864

2.  Plasma cytokines associated with febrile status epilepticus in children: A potential biomarker for acute hippocampal injury.

Authors:  William B Gallentine; Shlomo Shinnar; Dale C Hesdorffer; Leon Epstein; Douglas R Nordli; Darrell V Lewis; L Matthew Frank; Syndi Seinfeld; Ruth C Shinnar; Karen Cornett; Binyi Liu; Solomon L Moshé; Shumei Sun
Journal:  Epilepsia       Date:  2017-04-27       Impact factor: 5.864

Review 3.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

4.  Cerebrospinal fluid analysis after unprovoked first seizure.

Authors:  Vaso Zisimopoulou; Margarita Mamali; Serafeim Katsavos; Anna Siatouni; Antonios Tavernarakis; Stylianos Gatzonis
Journal:  Funct Neurol       Date:  2016 Apr-Jun

Review 5.  Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.

Authors:  Giovanna Vitaliti; Piero Pavone; Fahad Mahmood; Giuseppe Nunnari; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

6.  Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation.

Authors:  Martin N Stienen; Aiden Haghikia; Hannes Dambach; Jan Thöne; Martin Wiemann; Ralf Gold; Andrew Chan; Rolf Dermietzel; Pedro M Faustmann; Daniel Hinkerohe; Nora Prochnow
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 7.  Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword.

Authors:  Susan D Croll; Jeffrey H Goodman; Helen E Scharfman
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

Review 8.  Causes of CNS inflammation and potential targets for anticonvulsants.

Authors:  Mercé Falip; Xavier Salas-Puig; Carlos Cara
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

Review 9.  Outcome predictors for status epilepticus--what really counts.

Authors:  Raoul Sutter; Peter W Kaplan; Stephan Rüegg
Journal:  Nat Rev Neurol       Date:  2013-08-06       Impact factor: 42.937

10.  High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus.

Authors:  Shin-Seok Lee; Sukhminder Singh; Kimberly Link; Michelle Petri
Journal:  Semin Arthritis Rheum       Date:  2008-01-25       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.